FDA 483 - Wyeth Pharmaceutical Division of Wyeth Holdings LLC - March 17, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Wyeth Pharm. Div. of Wyeth Holdings LLC, Pfizer Inc. in Pearl River, NY, was inspected and cited for multiple deficiencies related to sterile drug product manufacturing. Observations included failures in microbiological contamination prevention, inadequate quality control unit oversight, poor equipment maintenance, and insufficient laboratory and utility controls. These issues indicate a lack of adherence to GMP standards, potentially impacting drug product safety and quality.
- Inspection Date
- March 17, 2017
- Product Type
- Drugs
ID · 020b7641-509c-477d-be4c-e22858cbf6d9